| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Parshall B Lynne is a Director at IONIS PHARMACEUTICALS INC with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 16 sells.
Estimated insider holdings value: $5.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2024 | CYTK Cytokinetics Inc | Director | Sale+OE | 5,000 | $54.22 | $271,100.00 | -19.5% | -3.5% | -38.5% | |
| Jun 17, 2024 | CYTK Cytokinetics Inc | Director | Sale+OE | 5,000 | $52.55 | $262,750.00 | -19.5% | +7.5% | -38.3% | |
| Jun 3, 2024 | CYTK Cytokinetics Inc | Director | Sale+OE | 5,000 | $48.64 | $243,200.00 | -24.3% | +9.4% | -35.8% | |
| Dec 28, 2023 | IONS Ionis Pharmaceuticals Inc | Director | Sale+OE | 117,638 | $50.48 | $5,938,128.76 | -32.2% | -11.6% | -28.9% | |
| Sep 26, 2023 | IONS Ionis Pharmaceuticals Inc | Director | Sell | 10,000 | $45.13 | $451,268.00 | -10.8% | +10.8% | -11.4% | |
| Sep 1, 2022 | CYTK Cytokinetics Inc | Director | Sale+OE | 30,296 | $52.79 | $1,599,325.84 | -75.2% | -20.9% | -33.0% | |
| Nov 5, 2021 | CYTK Cytokinetics Inc | Director | Sale+OE | 30,996 | $40.00 | $1,239,840.00 | -60.8% | -21.9% | -8.2% | |
| Oct 19, 2021 | CYTK Cytokinetics Inc | Director | Sale+OE | 10,332 | $35.73 | $369,206.79 | -50.8% | -8.3% | +33.4% | |
| Dec 23, 2020 | IONS Ionis Pharmaceuticals Inc | Director | Sell | 10,000 | $60.00 | $600,000.00 | -14.8% | - | - | |
| Nov 25, 2020 | IONS Ionis Pharmaceuticals Inc | Director | Sale+OE | 3,590 | $50.05 | $179,679.50 | -5.1% | - | - |